Albemarle (ALB) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Albemarle

NYSE•Basic Materials•Specialty Chemicals

$115.05+5.58(0.05%)After hours

Market Cap

$13.62B

P/E

60.7x

P/S

2.3x

P/B

1.3x

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

How this company scores

GoodMetricSide Score: 71/100

Strongest: Balance Sheet & Red Flags (24/25); weakest: Cash & Earnings Quality (12/25).

Profitability13/25

Growth22/25

Balance Sheet & Red Flags24/25

Cash & Earnings Quality12/25

Strengths

Growing revenueRising earningsLow leverageInterest easily covered

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 60.7x5y range 6.0x – 221.7x

Currently above its 12-quarter median.

P/S · 2.3x5y range 1.5x – 8.2x

Currently near its 20-quarter median.

P/B · 1.3x5y range 0.7x – 4.9x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg -0.2x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $13.62B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $5.91B
Q. Revenue: $1.74B
TTM EBITDA: $893.88M
TTM Op. Income: $252.08M
Q. Op. Income: $452.94M
TTM Net Income: $224.18M
Q. Net Income: $479.96M
EPS: $3.72
Shares Out.: $117.96M

$5.91B in TTM revenue grew 18.3% YoY, reaching $1.74B last quarter. TTM EBITDA of $893.88M and TTM operating income of $252.08M show growth is flowing through to the bottom line. TTM net income of $224.18M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 3 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 33.9%
EBITDA Margin: 34.9%
Op. Margin: 26.0%
Net Margin: 27.5%

Op. margin of 26.0% is up 22.4% YoY — cost efficiency is improving. Net margin at 27.5% and gross margin of 33.9% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 3 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 60.7x
P/S Ratio: 2.3x
P/B Ratio: 1.3x

At 60.7x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 2.3x and P/B of 1.3x provide additional context. Use the growth and margin sections to judge whether the multiple is justified.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $15.91B
Cash: $1.63B
Long-Term Debt: $1.80B
Book Value: $10.28B
D/E Ratio: 0.2
Debt/EBITDA: 3.0

With $15.91B in assets and $1.80B in long-term debt, D/E is 0.2and book value is $10.28B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $710.00M
TTM Free Cash Flow: $1.34B
FCF Margin: 22.7%
FCF / Net Income: 6.0

TTM FCF of $1.34B on $710.00M in operating cash flow. The FCF / Net Income ratio of 6.0x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 839% — an improving trend.